Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Ablynx to present at the 35th annual J.P. Morgan Healthcare Conference

Written by NDS on in the category news with the tags .


Ablynx will present at the 35th Annual J.P. Morgan Healthcare Conference on Thursday 12 January, at 1.30 am CET (Wednesday 11 January 2017 at 4:30 p.m. PST).

The annual J.P. Morgan Healthcare Conference event is one of the largest life sciences conferences of the year. It brings thousands of investors and executives from around the world to San Francisco where companies present their latest innovations hoping to find their next partner or investor.

Livecast

The presentation will be given by Dr Edwin Moses, CEO of Ablynx and will be casted live. You can access the presentation via this linkTo ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.

A replay of the webcast will also be made available on the Company's website, under the news & events section, for a period of 90 days following the presentation.

Read all Ablynx news
 

J.P. Morgan Healthcare Conference

January 9, 2017 to January 13, 2017
Westin St. Francis Hotel
335 Powell Street
San Francisco, CA, US

You may also like this: Biotech Financials : Part 1 - The bigger the company, the bigger the money
 

Read more about: .

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK KU Leuven Biowin UGent Janssen Itera Life Science V-Bio Ventures Turnstone XpandInnovation Flanders.bio

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.